The two current slimming drugs available on the NHS have side effects that preclude many people from using them: Xenical, also known as orlistat, cannot be used by those with bowel problems; Reductil, or sibutramine, cannot be used by those with high blood pressure.
So a third drug has been added to the repertoire – although banned in America!
Acomplia, also known as rimonabant, went on sale in Britain in June 2006 but approval from the National Institute for Health and Clinical Excellence, or NICE, for use on the NHS was issued only yesterday.
In July last year, the European Medicines Agency warned that rimonabant may be unsafe for patients suffering major depression or who were taking antidepressants.
Evidence suggested one in ten of those taking the drug may develop mental side-effects including low mood and depression, anxiety, irritability, nervousness and sleep disorders.
Obesity is of course a major problem – but are any of these drugs the answer?
Click here to read the full story.
Â
